A major breakthrough in cancer research is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital cancer protector protein is frequently inactivated in many types of cancer, leading https://yxzbookmarks.com/story21956641/mini-antibodies-revive-p53-the-new-approach-for-cancer-management